Samuel McLenachan
- Molecular Biology
- Ophthalmology top 1%
- Cellular and Molecular Neuroscience top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Neurology top 5%
- Co-authors
- Fred K. ChenAnn M. TurnleyYona GoldshmitPaul G. McMenaminDan ZhangMichael J. EdelElizabeth RakoczyHolly R. Chinnery
- Topics
- Retinal Development and Disorders (40 papers)CRISPR and Genetic Engineering (27 papers)Retinal Diseases and Treatments (21 papers)
- Partner nations
- AustraliaSpainUnited Kingdom
In The Last Decade
Samuel McLenachan
74 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 575
- Ophthalmology 374
- Cellular and Molecular Neuroscience 216
- Radiology, Nuclear Medicine and Imaging 203
- Neurology 152
Countries citing papers authored by Samuel McLenachan
This map shows the geographic impact of Samuel McLenachan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel McLenachan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel McLenachan more than expected).
Fields of papers citing papers by Samuel McLenachan
This network shows the impact of papers produced by Samuel McLenachan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel McLenachan. The network helps show where Samuel McLenachan may publish in the future.
Co-authorship network of co-authors of Samuel McLenachan
This figure shows the co-authorship network connecting the top 25 collaborators of Samuel McLenachan. A scholar is included among the top collaborators of Samuel McLenachan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel McLenachan. Samuel McLenachan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 13 | |
| 6 | 2 | |
| 7 | 9 | |
| 8 | 17 | |
| 9 | 27 | |
| 10 | 15 | |
| 11 | 2 | |
| 12 | 5 | |
| 13 | 11 | |
| 14 | 3 | |
| 15 | 17 | |
| 16 | 8 | |
| 17 | 35 | |
| 18 | 12 | |
| 19 | 41 | |
| 20 | 11 |
About Samuel McLenachan
Samuel McLenachan is a scholar working on Ophthalmology, Neurology and Molecular Biology, having authored 77 papers that have together received 1.1k indexed citations. Recurring topics across this work include Retinal Development and Disorders (40 papers), CRISPR and Genetic Engineering (27 papers) and Retinal Diseases and Treatments (21 papers). The work is most often cited by research in Ophthalmology (374 citations), Developmental Neuroscience (110 citations) and Neurology (152 citations). Samuel McLenachan has collaborated with scholars based in Australia, Spain and United Kingdom. Frequent co-authors include Fred K. Chen, Ann M. Turnley, Yona Goldshmit, Paul G. McMenamin, Dan Zhang, Michael J. Edel, Elizabeth Rakoczy, Holly R. Chinnery, Panos Ioannou and Xiangting Chen. Their work appears in journals such as PLoS ONE, Brain Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.